Navigation Links
Viral curiosity spreads across continents
Date:4/22/2013

WHAT: Biologist Esteban Engel, Ph.D., was named by The Pew Charitable Trusts as the "Biomedical Researcher of the Month," for his innovative work in neurovirologythe study of viruses infecting the nervous system. As a postdoctoral researcher in the Princeton University laboratory of Lynn Enquist, Ph.D., Dr. Engel studies the spread of herpes simplex virus type 1 (HSV-1)which, in rare cases, can lead to blindness or lethal encephalitis.

Dr. Engel's story is part of a "Biomedical Researcher of the Month" series launched by Pew, and is the first to feature a Latin American fellow. Pew's Latin American fellows program gives individuals like Engel, who hails from Chile, an opportunity to further their scientific knowledge by promoting exchange and collaboration between investigators in the United States and Latin America. Since 1991, Pew's biomedical programs have provided funding to more than 200 young scientists from Latin America to receive postdoctoral training in the United States, resulting in advances that span continents.

WHO: Experts are available for interviews regarding Dr. Engel's research and the program:

  • Esteban Engel, Ph.D., postdoctoral fellow, Department of Molecular Biology, Princeton Neuroscience Institute, Princeton University
  • Anita Pepper, Ph.D., director of the Pew Programs in the Biomedical Sciences Pepper is the director of The Pew Charitable Trusts' biomedical programs, which include both the Latin American fellows and the Pew scholars program.

WHERE: Visit http://www.pewhealth.org/other-resource/Interview-with-Pew-Latin-American-Fellow-Esteban-Engel-85899469672 to read the full question-and-answer story, which covers both Dr. Engel's research and his motivation to conduct it in the United States.

CONTACT: Chelsea Toledo at 202-540-6846, ctoledo@pewtrusts.org


'/>"/>

Contact: Chelsea Toledo
ctoledo@pewtrusts.org
202-540-6846
Pew Health Group
Source:Eurekalert

Related biology news :

1. Recreational use of HIV antiretroviral drug linked to its psychoactivity
2. Antiviral lipid earns patent
3. Early antiretroviral treatment reduces viral reservoirs in HIV-infected teens
4. Study: Viral reactivation a likely link between stress and heart disease
5. Protein production: Going viral
6. Viral alliances overcoming plant defenses
7. New study shows promise in using RNA nanotechnology to treat cancers and viral infections
8. The physics of going viral
9. Vitamin D supplements may protect against viral infections during the winter
10. Women & Infants participating in study of treatment of common viral infection in pregnancy
11. Discovery offers insight into treating viral stomach flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/1/2016)... NEW YORK , Feb. 1, 2016  Today, ... Heart Association (AHA) announced plans to develop a first ... cognitive computing power of IBM Watson. In the first ... disease, AHA, IBM (NYSE: IBM ), and Welltok ... metrics and health assessments with cognitive analytics, delivered on ...
(Date:1/25/2016)... Jan. 25, 2016  Glencoe Software, the world-leading supplier ... publication industries, will provide the data management solution OMERO ... Photo ... Phenotypic analysis measures the characteristics ... allowing comparisons between states such as health and disease, ...
(Date:1/20/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce the attainment of record-setting corporate ... of the company,s laser focus on (and growing international ... comprehensive, easy-to-use and highly affordable cloud-based technology platform. ... growth achievements in 2015 include: , Record ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... N.C. , Feb. 5, 2016  In the ... role for a host of launch activities including the ... of this launch activity is especially high in the ... Best Practices and the Role of Medical ... help companies focused on oncology therapies find better ways ...
(Date:2/5/2016)... FRANCISCO , February 5, 2016 ... a biotechnology company focused on developing products for ... has requested Rare Pediatric Disease Designation (RPDD) from the ... pigmentosa (RP) with MANF. MANF was previously granted orphan ... 2014. --> Amarantus BioScience Holdings, Inc. ...
(Date:2/4/2016)... CA (PRWEB) , ... February 04, 2016 , ... ... enterprise talent development and compliance training, today announced an interactive FDA compliance ... Playbook™. The RAPS (Regulatory Affairs Professional Society) accredited interactive course on Morf ...
(Date:2/4/2016)... , Feb. 4, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... announced today that Edward Lanphier , Sangamo,s president ... the progress of Sangamo,s ZFP Therapeutic ® development ... at 2:40 pm ET on Thursday, February 11, 2016, ... Healthcare Conference. The conference is being held in ...
Breaking Biology Technology: